Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumason for renal scarring ultrasound
NCT02786810Phase 2Completed
- Sponsor
- University of Tennessee
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sulfur hexafluoride in reflux nephropathy, sponsored by University of Tennessee. Primary endpoint: Visualization of Renal Scars Compared to Previous Imaging at 1 hour. Started Mar 2016; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
reflux nephropathy
Beyond the preview
Go deeper on NCT02786810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786810.